The Latest Breaking News from Vaccine

The HSE says that 6,000 people are at heightened risk from the virus but the initial vaccine rollout will only be offered to 600 people

Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.

With a strong HPV vaccination programme for girls and a concerted screening and treatment drive for women, the country could be the first in Africa to eliminate the disease

Fainting and fatigue may signal onset of variant, experts say

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Academics in Canada looked at data on 85,162 births where half of the mothers had received a coronavirus vaccine during pregnancy.

The Joint Committee on Vaccination and Immunisation has confirmed which vaccines are appropriate for the autumn booster following the new dual variant vaccine that targets Omicron and original variant.

Some areas could be without jabs for three to four weeks